Ship in Europe, Find out rates!
Language
Co-carnetin B12 500mg Buccal Solution 10 Vials 10ml
ALFASIGMA
SKU
021852013
Special Price
€15.78
Regular Price
€18.90
Save... €3.12
-17%
Recent lowest price:
€15.88
In stock
NAME
CO-CARNETIN B 12 500 MG + 2 MG POWDER AND SOLVENT FOR ORAL SUSPENSION
PHARMACOTHERAPEUTIC CATEGORY
Gastrointestinal and metabolic drugs.
ACTIVE PRINCIPLES
One cap contains: cobamamide 2000 mcg. One bottle contains: L-Carnitine internal salt 500 mg.
EXCIPIENTS
One cap contains: polyethylene glycol 4000 7 mg, mannitol powder 161 mg. One bottle contains: sorbitol 70% solution 4.075 g, sodium benzoate 0.048 g, black cherry juice 0.98 g, barley juice 0.98 g, sucrose 1.5 g, demineralized water to 10 ml.
INDICATIONS
Pediatrics: all states of malnutrition in children, infants and premature babies, growth retardations, weight insufficiency, dystrophies, anorexias, weight loss from any cause, post-infectious debilitation. Internal medicine: pathological slimming of any aetiology, thinness without apparent cause, inappetence, asthenia, convalescence, as an anti-catabolic in protracted cortisone therapies and in thyrotoxicosis, in hypoproteinemia of hepatopathies and nephrosis.
CONTRAINDICATIONS / SECONDARY EFFECT
Individual hypersensitivity already ascertained to the product.
DOSAGE
Infants and premature babies: one bottle of 'diluted in water. Children and adolescents: 1-2 bottles of 'diluted in water. Adults: 2-3 bottles per day.
STORAGE
Store at a temperature not exceeding 25 degrees C.
WARNINGS
Given the particular lability and photosensitivity of Cobamamide, any solution of the product in liquids or its mixing in other foods must take place immediately before the time of administration. The drug is neither addictive nor addictive. Products containing cobamamide should not be administered to anemic subjects except on the basis of investigations aimed at establishing the exact nature of the anemia. No particular precautions are to be observed in the use of the drug.
INTERACTIONS
There are no known interactions with other drugs.
SIDE EFFECTS
Cases of seizures have been reported in patients with or without a history of seizure activity who received oral or intravenous levocarnitine.
PREGNANCY AND BREASTFEEDING
The product can be administered both during pregnancy and breastfeeding.
CO-CARNETIN B 12 500 MG + 2 MG POWDER AND SOLVENT FOR ORAL SUSPENSION
PHARMACOTHERAPEUTIC CATEGORY
Gastrointestinal and metabolic drugs.
ACTIVE PRINCIPLES
One cap contains: cobamamide 2000 mcg. One bottle contains: L-Carnitine internal salt 500 mg.
EXCIPIENTS
One cap contains: polyethylene glycol 4000 7 mg, mannitol powder 161 mg. One bottle contains: sorbitol 70% solution 4.075 g, sodium benzoate 0.048 g, black cherry juice 0.98 g, barley juice 0.98 g, sucrose 1.5 g, demineralized water to 10 ml.
INDICATIONS
Pediatrics: all states of malnutrition in children, infants and premature babies, growth retardations, weight insufficiency, dystrophies, anorexias, weight loss from any cause, post-infectious debilitation. Internal medicine: pathological slimming of any aetiology, thinness without apparent cause, inappetence, asthenia, convalescence, as an anti-catabolic in protracted cortisone therapies and in thyrotoxicosis, in hypoproteinemia of hepatopathies and nephrosis.
CONTRAINDICATIONS / SECONDARY EFFECT
Individual hypersensitivity already ascertained to the product.
DOSAGE
Infants and premature babies: one bottle of 'diluted in water. Children and adolescents: 1-2 bottles of 'diluted in water. Adults: 2-3 bottles per day.
STORAGE
Store at a temperature not exceeding 25 degrees C.
WARNINGS
Given the particular lability and photosensitivity of Cobamamide, any solution of the product in liquids or its mixing in other foods must take place immediately before the time of administration. The drug is neither addictive nor addictive. Products containing cobamamide should not be administered to anemic subjects except on the basis of investigations aimed at establishing the exact nature of the anemia. No particular precautions are to be observed in the use of the drug.
INTERACTIONS
There are no known interactions with other drugs.
SIDE EFFECTS
Cases of seizures have been reported in patients with or without a history of seizure activity who received oral or intravenous levocarnitine.
PREGNANCY AND BREASTFEEDING
The product can be administered both during pregnancy and breastfeeding.
| Destination | Cost | Detail |
|---|---|---|
| Italy | €5,90* | 24/72H |
| Austria, France, Germany, Slovenia | € 13* | 3 days |
| Belgium, Luxembourg, Portugal, Netherlands, Spain | € 14* | 4 days |
| Bulgary, Cechia, Hungary, Poland, Romania, Slovakia | € 19* | 5 days |
| Denmark, Estonia, Finland, Ireland, Lithuania, Latvia ,Sweden | € 22* | 5 days |
| United Kingdom, Switzerland, Greece | € 30* | 7 days |
| Canada, USA | € 40 | 7 Days |
European shipments with express courier: FedEx, MBE, DHL
*For the shipment outside band B ther's an extra cost of 22€ *For the shipment outside band C ther's an extra cost of 30€ Delivery Times exclude Saturday and Holidays
For Islands and Areas of difficult Accessibility the shipments are made in 72 hours and the cost will be increased by 15€
The images of the products shown on our site are purely indicative and may differ in shape, color, text and packaging shown on them. Given the difficulty of updating all the products on our site in real time or any errors, XFarma.it, all products will be identified through SKU MINSAN (code of the Ministry of Health).
The transport of medicines sold online is carried out in compliance with the guidelines on good distribution practice according to Article 112-quater, paragraph 10. (Italy)